A Clinical Trial to Examine the Efficacy of a Supplement to Support Hormone Regulation in Women

Scale Media Inc

Status: Active, not recruiting

Conditions: Hormone Regulation

Treatments: Dietary Supplement: Beyond Hormone; Other: Placebo

Study type: Interventional

Funder types: Industry

Identifiers

NCT06531668

20431

Details and patient eligibility

About

This randomized, triple-blind, placebo-controlled trial will evaluate the efficacy of Live Conscious's Beyond Hormone supplement in regulating hormone production in women. The study involves 50 generally healthy female participants aged 25-45 who are not menopausal. The trial spans three menstrual cycles and assesses both objective hormone levels and subjective well-being through blood tests and questionnaires, respectively.

Enrollment: 50 patients

Sex: Female

Ages: 25 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Female at-birth, aged 25-45.
• Not menopausal or perimenopausal.
• Regularly menstruating.
• Not taking any medication, supplement, or vitamin affecting hormone levels.
• Generally healthy and not living with any uncontrolled chronic disease.

Exclusion criteria

• Medical conditions or treatments affecting hormonal regulation.
• Endocrine disorders, gynecological or reproductive health conditions.
• Use of hormonal contraceptives or hormone therapy.
• Recent major illness or surgery.
• Severe allergies or hypersensitivities.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

50 participants in 2 patient groups, including a placebo group

Beyond Hormone Supplement

Experimental group

Description:

Participants in this arm will receive the Beyond Hormone supplement.

Treatment:

Dietary Supplement: Beyond Hormone

Placebo

Placebo Comparator group

Description:

Participants in this arm will receive a placebo consisting of rice flour encapsulated in a vegetable cellulose capsule.

Treatment:

Other: Placebo